The Canadian government will invest $26.6 million U.S. toward producing and distributing medical isotopes and radiopharmaceuticals.
The funds will support the Canadian Medical Isotope Ecosystem, a pan-Canadian consortium launched on June 27 that includes the indigenous group Saugeen Ojibway Nation as well as the nuclear industry, leading research facilities, academics, and firms working to commercialize novel therapies.
"We will be expanding production [of lutetium-177] to double it by 2024-2025," Bruce Power Chief Executive Michael Rencheck told Reuters.
The partnership is expected to create or maintain more than 600 jobs and 30 internship opportunities for Canadians, as well as advance Canadian expertise on medical isotopes.
